Cargando…

Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance

PURPOSE: To investigate the association of human papillomavirus (HPV) status with p16, p53, and TLR9 expression in head and neck squamous cell carcinoma (HNSCC) and to evaluate these proteins as potential surrogate prognostic markers. METHODS: Expression of p16, p53, and TLR9 was assessed by immunoh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shu, Zhuang, Xibing, Gao, Caixia, Qiao, Tiankui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873021/ https://www.ncbi.nlm.nih.gov/pubmed/33574680 http://dx.doi.org/10.2147/OTT.S293163

Ejemplares similares

The Preliminary Study for Postoperative Radiotherapy Survival Associated with RUNX3 and TLR9 Expression in Lung Cancer
por: Gao, Caixia, et al.
Publicado: (2021)

Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma
por: Xie, Xiujie, et al.
Publicado: (2013)

TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression
por: Gao, Caixia, et al.
Publicado: (2018)

Assessment of immunohistochemical expression of p16 in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters
por: Pandey, Pinki, et al.
Publicado: (2021)

Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients
por: Jiarpinitnun, Chuleeporn, et al.
Publicado: (2020)

Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma
por: O’Neill, W. Quinn, et al.
Publicado: (2022)

Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta‐analysis on HPV, p16, and TP53
por: Mulder, Frans J., et al.
Publicado: (2020)

Immunohistochemical over expression of p53 in head and neck Squamous cell carcinoma: clinical and prognostic significance
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16
por: Biesaga, Beata, et al.
Publicado: (2017)

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
por: Mineta, H., et al.
Publicado: (1998)

The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma
por: Pastrez, Paula Roberta Aguiar, et al.
Publicado: (2017)

An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma
por: Carper, Miranda B., et al.
Publicado: (2019)

Activation of the P62-Keap1-NRF2 Pathway Protects against Ferroptosis in Radiation-Induced Lung Injury
por: Li, Xuan, et al.
Publicado: (2022)

Dual role for p16 in the metastasis process of HPV positive head and neck cancers
por: Dok, Rüveyda, et al.
Publicado: (2017)

Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer
por: Smith, Elaine M, et al.
Publicado: (2010)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

Significance of the Neutrophil-to-Lymphocyte Ratio in p16-Negative Squamous Cell Carcinoma of Unknown Primary in Head and Neck
por: Xu, Chunmiao, et al.
Publicado: (2020)

Multiomics Differences in Lung Squamous Cell Carcinoma Patients with High Radiosensitivity Index Compared with Those with Low Radiosensitivity Index
por: Du, Yajing, et al.
Publicado: (2021)

Long non-coding RNA MIR4435-2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR-383-5p/RBM3 axis
por: Wang, Shu, et al.
Publicado: (2021)

A HPV16-related prognostic indicator for head and neck squamous cell carcinoma
por: Zhang, Qian, et al.
Publicado: (2020)

Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes
por: Arsa, Lalida, et al.
Publicado: (2021)

Clinicopathological Significance of Expression of CD44 Variants in Head and Neck Squamous Cell Carcinoma
por: Kanke, Minoru, et al.
Publicado: (2000)

A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
por: Balk, Matthias, et al.
Publicado: (2023)

p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
por: Ganly, I, et al.
Publicado: (2000)

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments
por: de Bakker, Tycho, et al.
Publicado: (2022)

p53 codon 72 polymorphism association with head and neck squamous cell carcinoma
por: Mojtahedi, Zahra, et al.
Publicado: (2015)

p53 in colorectal cancer: clinicopathological correlation and prognostic significance.
por: Scott, N., et al.
Publicado: (1991)

Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment
por: Qi, Ruixue, et al.
Publicado: (2016)

Penile cancer with positive nodes: A case of HPV p16-positivity and its significance, implication of data from head and neck cancer
por: Nguyen, Cam, et al.
Publicado: (2019)

HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?
por: da Costa, Allini Mafra, et al.
Publicado: (2017)

p63 Directs Subtype-Specific Gene Expression in HPV+ Head and Neck Squamous Cell Carcinoma
por: Glathar, Alexandra Ruth, et al.
Publicado: (2022)

The Role of the p16 and p53 Tumor Suppressor Proteins and Viral HPV16 E6 and E7 Oncoproteins in the Assessment of Survival in Patients with Head and Neck Cancers Associated with Human Papillomavirus Infections
por: Lifsics, Andrejs, et al.
Publicado: (2023)

p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
por: Nylander, K., et al.
Publicado: (1995)

High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore
por: Tan, Louise Soo Yee, et al.
Publicado: (2016)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
por: Cochicho, Daniela, et al.
Publicado: (2021)

HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
por: Wasserman, Jason K., et al.
Publicado: (2017)

Novel p53 therapies for head and neck cancer
por: Castellanos, Mario R., et al.
Publicado: (2016)

High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-κB signaling pathway in non-small cell lung cancer cells
por: Chen, Xue, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o79dhv51vl077hpofehamkjsi7